BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38155543)

  • 21. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.
    Ahadi MS; Fuchs TL; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
    Histopathology; 2022 May; 80(6):906-921. PubMed ID: 34951482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcomatoid salivary duct carcinoma of the parotid gland.
    Henley JD; Seo IS; Dayan D; Gnepp DR
    Hum Pathol; 2000 Feb; 31(2):208-13. PubMed ID: 10685635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary heterologous carcinosarcoma (metaplastic carcinoma) of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural analysis of eight cases and a review of the literature.
    Perret L; Chaubert P; Hessler D; Guillou L
    Cancer; 1998 Apr; 82(8):1535-49. PubMed ID: 9554532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
    Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
    Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.
    Taskin OC; Akkas G; Memis B; Seven IE; Basturk O; Jang KT; Roa JC; Araya JC; Bellolio E; Losada H; Sarmiento J; Balci S; Pehlivanoglu B; Reid MD; Koshiol J; Adsay V
    Virchows Arch; 2019 Jul; 475(1):59-66. PubMed ID: 31177317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
    Lopez-Beltran A; Pacelli A; Rothenberg HJ; Wollan PC; Zincke H; Blute ML; Bostwick DG
    J Urol; 1998 May; 159(5):1497-503. PubMed ID: 9554341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal Carcinoma With a Sarcomatoid Component: A Case Report With Detailed Immunohistochemistry, Molecular Analysis, and Literature Review.
    Todori M; Yanagawa N; Ito K; Ito Y; Suzuki M; Sugimoto R; Osakabe M; Uesugi N; Sugai T
    Int J Surg Pathol; 2023 Dec; 31(8):1548-1552. PubMed ID: 36890707
    [No Abstract]   [Full Text] [Related]  

  • 28. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
    Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
    Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [SMARCA4-deficient undifferentiated carcinoma of the gastrointestinal tract: a clinicopathological and immunohistochemical study of nine cases].
    Zhu PP; Li XX; Liu JH; Du XL; Su HY; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):868-874. PubMed ID: 36097904
    [No Abstract]   [Full Text] [Related]  

  • 31. Sarcomatoid carcinoma of the prostate: a case report.
    Zizi-Sermpetzoglou A; Savvaidou V; Tepelenis N; Galariotis N; Olympitis M; Stamatiou K
    Int J Clin Exp Pathol; 2010 Feb; 3(3):319-22. PubMed ID: 20224731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.
    Chang B; Sheng W; Wang L; Zhu X; Tan C; Ni S; Weng W; Huang D; Wang J
    Am J Surg Pathol; 2022 Jul; 46(7):889-906. PubMed ID: 34812766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients.
    Ikegami H; Iwasaki H; Ohjimi Y; Takeuchi T; Ariyoshi A; Kikuchi M
    Hum Pathol; 2000 Mar; 31(3):332-40. PubMed ID: 10746676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
    Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
    Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.
    Fatima N; Canter DJ; Carthon BC; Kucuk O; Master VA; Nieh PT; Ogan K; Osunkoya AO
    Can J Urol; 2015 Jun; 22(3):7783-7. PubMed ID: 26068625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.
    Agaimy A; Haller F; Frohnauer J; Schaefer IM; Ströbel P; Hartmann A; Stoehr R; Klöppel G
    Mod Pathol; 2015 Feb; 28(2):248-60. PubMed ID: 25103069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
    Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
    Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.
    Horton RK; Ahadi M; Gill AJ; Said S; Chen ZE; Bakhshwin A; Nichols M; Goldblum JR; Graham RP
    Am J Surg Pathol; 2021 Mar; 45(3):414-420. PubMed ID: 33027072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic and sarcomatoid carcinoma of the small intestine: a clinicopathologic study.
    Robey-Cafferty SS; Silva EG; Cleary KR
    Hum Pathol; 1989 Sep; 20(9):858-63. PubMed ID: 2777242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.